You can get a sense of what we support from this piece last year. We fund whatever we believe is important, neglected, and tractable across many areas of discovery and translation, which leads to a broad portfolio. Generalists very much welcome!

www.openphilanthropy.org/research/fiv...

Spotify likes to do a second transcript of its own, and gave you a new name:

I randomly sampled 1 day later and 1 block away from the original photo. Claim supported ✅

Reader, the gelato progressed

Wonderful & detailed piece as always from Saloni. The philosophical issue she discusses comes up a lot when we try to prioritise across interventions at @openphil.bsky.social - should we fund scientists making hep B drugs, or medical schools training hepatologists, or hep B screening programs, or..?

Running clinical trials of existing drugs against new indications/diseases can turn up happy results. These drugs are often off-patent, so it's an area where public and philanthropic funding can shine.

Nice profile of Cures Within Reach and @raykennedy.bsky.social's grants: